JP2022502431A5 - - Google Patents

Info

Publication number
JP2022502431A5
JP2022502431A5 JP2021517292A JP2021517292A JP2022502431A5 JP 2022502431 A5 JP2022502431 A5 JP 2022502431A5 JP 2021517292 A JP2021517292 A JP 2021517292A JP 2021517292 A JP2021517292 A JP 2021517292A JP 2022502431 A5 JP2022502431 A5 JP 2022502431A5
Authority
JP
Japan
Prior art keywords
integer
formula
alkyl
ch2ch2o
cycloalkanediyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021517292A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022502431A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2019/001114 external-priority patent/WO2020065408A1/en
Publication of JP2022502431A publication Critical patent/JP2022502431A/ja
Publication of JP2022502431A5 publication Critical patent/JP2022502431A5/ja
Priority to JP2024106489A priority Critical patent/JP7830555B2/ja
Pending legal-status Critical Current

Links

JP2021517292A 2018-09-27 2019-09-27 スルホマレイミドに基づくリンカーおよび対応する複合体 Pending JP2022502431A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024106489A JP7830555B2 (ja) 2018-09-27 2024-07-01 スルホマレイミドに基づくリンカーおよび対応する複合体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18306270.2 2018-09-27
EP18306270 2018-09-27
PCT/IB2019/001114 WO2020065408A1 (en) 2018-09-27 2019-09-27 Sulfomaleimide-based linkers and corresponding conjugates

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024106489A Division JP7830555B2 (ja) 2018-09-27 2024-07-01 スルホマレイミドに基づくリンカーおよび対応する複合体

Publications (2)

Publication Number Publication Date
JP2022502431A JP2022502431A (ja) 2022-01-11
JP2022502431A5 true JP2022502431A5 (https=) 2022-10-11

Family

ID=63857832

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021517292A Pending JP2022502431A (ja) 2018-09-27 2019-09-27 スルホマレイミドに基づくリンカーおよび対応する複合体
JP2024106489A Active JP7830555B2 (ja) 2018-09-27 2024-07-01 スルホマレイミドに基づくリンカーおよび対応する複合体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024106489A Active JP7830555B2 (ja) 2018-09-27 2024-07-01 スルホマレイミドに基づくリンカーおよび対応する複合体

Country Status (11)

Country Link
US (2) US12011485B2 (https=)
EP (1) EP3856258B1 (https=)
JP (2) JP2022502431A (https=)
KR (1) KR102858995B1 (https=)
CN (1) CN113453724B (https=)
AU (1) AU2019350536B2 (https=)
BR (1) BR112021005655A2 (https=)
CA (1) CA3113378C (https=)
MX (1) MX2021003295A (https=)
WO (1) WO2020065408A1 (https=)
ZA (1) ZA202101990B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201908886D0 (en) * 2019-06-20 2019-08-07 Almac Discovery Ltd Anthracycline derivatives
WO2024008102A1 (en) * 2022-07-05 2024-01-11 Wuxi Xdc (Shanghai) Co., Ltd. Linker for conjugation
WO2024235120A1 (zh) * 2023-05-12 2024-11-21 四川科伦博泰生物医药股份有限公司 稠环化合物及其制备方法和用途
CN119751374A (zh) * 2024-12-09 2025-04-04 中国科学院水生生物研究所 高抑菌活性、低生态毒性的异噻唑啉酮类化合物及其制备方法和应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4127687A (en) * 1976-07-19 1978-11-28 Rohm And Haas Company Prevention of fouling of marine structures such as boat hulls
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
GB9014932D0 (en) 1990-07-05 1990-08-22 Celltech Ltd Recombinant dna product and method
JPH04248881A (ja) 1991-01-25 1992-09-04 Mitsubishi Kasei Corp 顔料分散型水性記録液
JPH04261476A (ja) 1991-02-15 1992-09-17 Mitsubishi Kasei Corp インクジェットプリンター用クリーニング液
WO1994004679A1 (en) 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
JPH05244982A (ja) 1991-12-06 1993-09-24 Sumitomo Chem Co Ltd 擬人化b−b10
US5639641A (en) 1992-09-09 1997-06-17 Immunogen Inc. Resurfacing of rodent antibodies
TW258789B (https=) 1992-09-28 1995-10-01 Rohm & Haas
KR20070110327A (ko) * 2005-03-08 2007-11-16 미쓰비시 가가꾸 가부시키가이샤 이방성 색소 필름용 조성물, 이방성 색소 필름 및 편광소자
JP2007025635A (ja) * 2005-06-17 2007-02-01 Fujitsu Hitachi Plasma Display Ltd プラズマディスプレイ装置及びその処理方法
US20060293374A1 (en) 2005-06-24 2006-12-28 Beers Scott A Substituted isothiazolones
CN101397280A (zh) 2008-11-04 2009-04-01 东华大学 反应性异噻唑啉酮类抗菌整理剂的制备方法
DE102012213321A1 (de) * 2012-07-30 2014-01-30 Robert Bosch Gmbh Verfahren und Vorrichtung zum Betreiben eines Fahrzeugs
FR3005051A1 (fr) 2013-04-25 2014-10-31 Pf Medicament Derives de la dolastatine 10 et d'auristatines
US9840533B2 (en) 2013-04-29 2017-12-12 Memorial Sloan Kettering Cancer Center Compositions and methods for altering second messenger signaling
US10781259B2 (en) * 2013-06-06 2020-09-22 Magenta Therapeutics, Inc. Modified antibodies and related compounds, compositions, and methods of use
CN106456602B (zh) 2014-03-27 2020-11-24 范德比尔特大学 取代的吲哚mcl-1抑制剂
HRP20190888T8 (hr) 2014-04-25 2019-10-04 Pierre Fabre Médicament Konjugat antitijela za igf-1r i lijeka i njegova upotreba u liječenju karcinoma
HUE047952T2 (hu) 2014-04-25 2020-05-28 Pf Medicament Ellenanyag-drog konjugátum és alkalmazása rák kezelésében történõ alkalmazásra
DK3134438T3 (da) 2014-04-25 2020-12-07 Pf Medicament IGF-1R-antistof og anvendelse heraf som adresseringsvehikel til behandling af cancer
CN104230916B (zh) * 2014-09-30 2020-04-28 上海化学试剂研究所有限公司 一种异噻唑啉酮类化合物及其制备方法和应用
EP3209334A2 (en) * 2014-10-20 2017-08-30 Igenica Biotherapeutics, Inc. Novel antibody-drug conjugates and related compounds, compositions, and methods of use
EP3546473B1 (en) 2014-12-16 2025-12-10 Kayla Therapeutics Fluorinated cyclic [(2',5')p(3',5')p]-dinucleotides for cytokine induction
EA035817B1 (ru) 2015-03-10 2020-08-14 Адуро Байотек, Инк. Композиции и способы для активации сигналинга, зависимого от "гена стимулятора интерферона"
CA2989269C (en) * 2015-06-15 2020-09-22 Robert Yongxin Zhao Hydrophilic linkers for conjugation of a cytotoxic agent or chromophore molecule to a cell-binding molecule
WO2017051254A1 (en) * 2015-09-25 2017-03-30 Legochem Biosciences, Inc. Compositions and methods related to anti-egfr antibody drug conjugates
US20180369268A1 (en) 2015-12-16 2018-12-27 Aduro Biotech, Inc. Methods for identifying inhibitors of "stimulator of interferon gene"- dependent interferon production
US11129910B2 (en) * 2016-02-04 2021-09-28 Hangzhou Dac Biotech Co., Ltd. Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof
PE20210255A1 (es) 2016-12-01 2021-02-10 Takeda Pharmaceuticals Co Dinucleotido ciclico como agonistas de sting (estimulador de genes de interferon)

Similar Documents

Publication Publication Date Title
AU2020202853B2 (en) PEGylated drug-linkers for improved Ligand-Drug Conjugate pharmacokinetics
JP2022502431A5 (https=)
JP7244987B2 (ja) 多剤抗体薬物コンジュゲート
JP2023512036A5 (https=)
RU2019105549A (ru) Гидрофильные саморазрушающиеся линкеры и их конъюгаты
AU2018368520B2 (en) Ligand-drug-conjugates as substrates for selective cleavage by the exopeptidase activity of Cathepsin B
JP2023520930A (ja) 電荷多様性リンカー
JP2022525704A5 (https=)
CN111542344A (zh) 包含单分子量聚肌氨酸的配体-药物-缀合物
JP2015524796A5 (ja) 細胞毒性剤と細胞結合受容体との共役体
EA037203B1 (ru) Конъюгаты антитело-лекарственное средство с самостабилизирующимися линкерами
JP2017528418A5 (https=)
RU2017101662A (ru) Конъюгаты антитела против фолатного рецептора альфа (fra) c лекарственным средством и способы их применения
JP7830555B2 (ja) スルホマレイミドに基づくリンカーおよび対応する複合体
JP2020519610A5 (https=)
JP2024528719A (ja) コンジュゲート化試薬及びそのコンジュゲート
CN118119409A (zh) 癌的治疗和/或预防用药物组合物
JP2024520853A5 (https=)
RU2021110933A (ru) Линкеры на основе сульфомалеимида и соответствующие конъюгаты
RU2815199C2 (ru) Линкеры на основе сульфомалеимида и соответствующие конъюгаты
Johannes et al. Protease-sensitive Linkers
WO2026051926A1 (zh) 一种基于依喜替康的抗体-药物偶联物及其制备方法和用途
WO2025206033A1 (ja) uPAR結合性HLHペプチド、ペプチド-薬物複合体および組成物
JP2025508819A5 (https=)
EA046139B1 (ru) Конъюгаты лиганда-лекарственного средства в качестве субстратов для селективного расщепления под действием экзопептидазной активности катепсина b